Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.77
-0.44 (-1.98%)
Apr 1, 2025, 4:00 PM EDT - Market closed

KNSA Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
1,5811,4281,2341,0428111,203
Upgrade
Market Cap Growth
15.76%15.76%18.45%28.46%-32.59%98.17%
Upgrade
Enterprise Value
1,3481,2151,046848617840
Upgrade
Last Close Price
21.7719.7817.5414.9811.7717.67
Upgrade
PE Ratio
--87.605.68--
Upgrade
Forward PE
21.1742.93----
Upgrade
PS Ratio
3.673.374.574.7321.04-
Upgrade
PB Ratio
3.603.262.812.634.383.86
Upgrade
P/TBV Ratio
3.383.382.932.764.893.86
Upgrade
P/FCF Ratio
62.2356.2093.67182.67--
Upgrade
P/OCF Ratio
61.5655.5992.76179.37--
Upgrade
EV/Sales Ratio
3.182.873.873.8516.02-
Upgrade
EV/EBITDA Ratio
--69.62--
Upgrade
EV/EBIT Ratio
--86.73--
Upgrade
EV/FCF Ratio
53.0347.8179.39148.64--
Upgrade
Debt / Equity Ratio
0.020.020.030.020.030.02
Upgrade
Debt / EBITDA Ratio
---0.38--
Upgrade
Debt / FCF Ratio
0.390.390.931.04--
Upgrade
Asset Turnover
0.770.770.550.640.13-
Upgrade
Inventory Turnover
6.586.583.413.72--
Upgrade
Quick Ratio
2.842.843.584.484.1510.16
Upgrade
Current Ratio
3.303.304.345.164.3810.46
Upgrade
Return on Equity (ROE)
-9.85%-9.85%3.37%63.10%-63.55%-60.07%
Upgrade
Return on Assets (ROA)
-5.15%-5.15%-3.19%1.76%-33.63%-32.57%
Upgrade
Return on Capital (ROIC)
-6.34%-6.34%-3.69%2.06%-38.39%-35.96%
Upgrade
Return on Capital Employed (ROCE)
---2.40%--
Upgrade
Earnings Yield
-2.73%-3.02%1.14%17.60%-19.48%-13.42%
Upgrade
FCF Yield
1.61%1.78%1.07%0.55%-15.63%-11.37%
Upgrade
Buyback Yield / Dilution
0.69%0.69%-2.13%-2.69%-10.89%-14.42%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q